Another example can be found in [100], which utilises genomics, transcriptomics, clinical, and IHC data; IHC data indicates the presence or absence of two important protein receptors in breast cancer cells, the oestrogen receptor and the progesterone receptor, which not only have prognostic value by themselves but are also targets of hormone therapy. This evidence concerns the gene PGR and breast cancer.